{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:19:31Z","timestamp":1794651571089,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Visceral leishmaniasis (VL) is a fatal form of leishmaniasis which affects 70 countries, worldwide. Increasing drug resistance, HIV co-infection, and poor health system require operative vaccination strategy to control the VL transmission dynamics. Therefore, a holistic approach is needed to generate T and B memory cells to mediate long-term immunity against VL infection. Consequently, immunoinformatics approach was applied to design\n                    <jats:italic>Leishmania<\/jats:italic>\n                    secretory protein based multi-epitope subunit vaccine construct consisting of B and T cell epitopes. Further, the physiochemical characterization was performed to check the aliphatic index, theoretical PI, molecular weight, and thermostable nature of vaccine construct. The allergenicity and antigenicity were also predicted to ensure the safety and immunogenic behavior of final vaccine construct. Moreover, homology modeling, followed by molecular docking and molecular dynamics simulation study was also performed to evaluate the binding affinity and stability of receptor (TLR-4) and ligand (vaccine protein) complex. This study warrants the experimental validation to ensure the immunogenicity and safety profile of presented vaccine construct which may be further helpful to control VL infection.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-08842-w","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T11:45:40Z","timestamp":1502279140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":329,"title":["Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach"],"prefix":"10.1038","volume":"7","author":[{"given":"Nazia","family":"Khatoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"key":"8842_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1590\/S0074-02762003000700001","volume":"98","author":"M De Almeida","year":"2003","unstructured":"De Almeida, M., Vilhena, V., Barral, A. & Barral-Netto, M. Leishmanial infection: analysis of its first steps. A review. Mem. Inst. Oswaldo. Cruz. \n                           98, 861\u2013870 (2003).","journal-title":"Mem. Inst. Oswaldo. Cruz."},{"key":"8842_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.apjtm.2015.06.008","volume":"8","author":"R Nagill","year":"2015","unstructured":"Nagill, R., Kaur, T., Joshi, J. & Kaur, S. Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis. Asian. Pac. J. Trop. Med. \n                           8, 513\u2013519 (2015).","journal-title":"Asian. Pac. J. Trop. Med."},{"key":"8842_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60395-6","volume":"385","author":"M Perry","year":"2015","unstructured":"Perry, M. et al. Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment-resistant kala-azar? Lancet. \n                           385, S80 (2015).","journal-title":"Lancet."},{"key":"8842_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/092986709787458489","volume":"16","author":"L Kedzierski","year":"2009","unstructured":"Kedzierski, L. et al. Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr. Med. Chem. \n                           16, 599\u2013614 (2009).","journal-title":"Curr. Med. Chem."},{"key":"8842_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4269\/ajtmh.13-0096","volume":"89","author":"VK Prajapati","year":"2013","unstructured":"Prajapati, V. K. et al. In vitro susceptibility of Leishmania donovani to miltefosine in indian visceral leishmaniasis. Am. J. Trop. Med. Hyg. \n                           89, 750\u2013754 (2013).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"8842_CR6","doi-asserted-by":"crossref","unstructured":"Masic, A. et al. Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB\/c Mice. PloS. One. 10, e0142386 (2015).","DOI":"10.1371\/journal.pone.0142386"},{"key":"8842_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.exppara.2013.07.021","volume":"135","author":"S Hazra","year":"2013","unstructured":"Hazra, S. et al. Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani. Exp. Parasitol. \n                           135, 407\u2013413, doi:10.1016\/j.exppara.2013.07.021 (2013).","journal-title":"Exp. Parasitol."},{"key":"8842_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0169-4758(00)01692-6","volume":"16","author":"M Rittig","year":"2000","unstructured":"Rittig, M. & Bogdan, C. Leishmania\u2013host-cell interaction: complexities and alternative views. Parasitol. Today. \n                           16, 292\u2013297 (2000).","journal-title":"Parasitol. Today."},{"key":"8842_CR9","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1098\/rstb.2011.0076","volume":"366","author":"B Greenwood","year":"2011","unstructured":"Greenwood, B., Salisbury, D. & Hill, A. V. Vaccines and global health. Philos. Trans. R. Soc. Lond. B. Biol. Sci. \n                           366, 2733\u20132742 (2011).","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"8842_CR10","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1017\/S0031182006001831","volume":"133","author":"L Kedzierski","year":"2006","unstructured":"Kedzierski, L., Zhu, Y. & Handman, E. Leishmania vaccines: progress and problems. Parasitology. \n                           133, S87\u2013S112 (2006).","journal-title":"Parasitology."},{"key":"8842_CR11","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","volume":"19","author":"A Misra","year":"2001","unstructured":"Misra, A. et al. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG. Vaccine. \n                           19, 3485\u20133492 (2001).","journal-title":"Vaccine."},{"key":"8842_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","volume":"92","author":"MA Horwitz","year":"1995","unstructured":"Horwitz, M. A., Lee, B., Dillon, B. J. & Harth, G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. \n                           92, 1530\u20131534 (1995).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"8842_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1745-7580-2-2","volume":"2","author":"JE Larsen","year":"2006","unstructured":"Larsen, J. E., Lund, O. & Nielsen, M. Improved method for predicting linear B-cell epitopes. Immunome. Res. \n                           2, 2 (2006).","journal-title":"Immunome. Res."},{"key":"8842_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-3024.2010.01219.x","volume":"32","author":"R Maurya","year":"2010","unstructured":"Maurya, R. et al. Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite. Immunol. \n                           32, 479\u2013483 (2010).","journal-title":"Parasite. Immunol."},{"key":"8842_CR15","first-page":"5446","volume":"11","author":"M Mirza","year":"2016","unstructured":"Mirza, M., Usman, M., Biuk-Aghai, R. P. & Fong, S. A Modular Approach for Implementation of Honeypots in Cyber Security. Int. J. Appl. Eng. Res. \n                           11, 5446\u20135451 (2016).","journal-title":"J. Appl. Eng. Res."},{"key":"8842_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1126\/science.1323878","volume":"257","author":"M Matsumura","year":"1992","unstructured":"Matsumura, M., Fremont, D. H., Peterson, P. A. & Wilson, I. A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. \n                           257, 927\u2013935 (1992).","journal-title":"Science."},{"key":"8842_CR17","doi-asserted-by":"crossref","unstructured":"Ansar, W. & Ghosh, S. In Biology of C Reactive Protein in Health and Disease 1-32 (Springer, 2016).","DOI":"10.1007\/978-81-322-2680-2_1"},{"key":"8842_CR18","volume":"5","author":"N Mahida","year":"2015","unstructured":"Mahida, N., Blythe, M., NDavies, M., Doytchinova, I. A. & Flower, D. R. Toward the Computer-aided Discovery and Design of Epitope Ensemble Vaccines. Post-Genomic Approaches in Drug and Vaccine. Development \n                           5, 205 (2015).","journal-title":"Development"},{"key":"8842_CR19","first-page":"383","volume":"62","author":"KN Srinivasan","year":"2004","unstructured":"Srinivasan, K. N., Brusic, V. & August, T. J. New technologies for vaccine development. Drug. Development. Res. \n                           62, 383\u2013392 (2004).","journal-title":"Res."},{"key":"8842_CR20","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock, K. L., Reits, E. & Neefjes, J. Present Yourself! By MHC Class I and MHC Class II Molecules. Trends. Immunol. \n                           37, 724\u2013737 (2016).","journal-title":"Trends. Immunol."},{"key":"8842_CR21","doi-asserted-by":"publisher","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","volume":"31","author":"J Alvar","year":"2013","unstructured":"Alvar, J. et al. Case study for a vaccine against leishmaniasis. Vaccine. \n                           31, B244\u2013B249 (2013).","journal-title":"Vaccine."},{"key":"8842_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/JCM.02029-06","volume":"45","author":"R Reithinger","year":"2007","unstructured":"Reithinger, R. & Dujardin, J.-C. Molecular diagnosis of leishmaniasis: current status and future applications. J. Clin. Microbiol. \n                           45, 21\u201325 (2007).","journal-title":"J. Clin. Microbiol."},{"key":"8842_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-346","volume":"14","author":"DB Craig","year":"2013","unstructured":"Craig, D. B. & Dombkowski, A. A. Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins. BMC. Bioinformatics. \n                           14, 346, doi:10.1186\/1471-2105-14-346 (2013).","journal-title":"BMC. Bioinformatics."},{"key":"8842_CR24","unstructured":"DeLano, W. L. PyMOL: A Molecular Graphics System. DeLano Scientific, Palo Alto, CA, USA.\u201d ESRF (Grenoble, France). https:\/\/www.pymol.org\/ (2002)."},{"key":"8842_CR25","doi-asserted-by":"publisher","unstructured":"Shukla, R. et al. Identification of potential inhibitors of Fasciola gigantica thioredoxin1: Computational screening, molecular dynamics simulation and binding free energy studies. J. Biomol. Struct. Dyn. 1-68, doi:10.1080\/07391102.2017.1344141 (2017).","DOI":"10.1080\/07391102.2017.1344141"},{"key":"8842_CR26","doi-asserted-by":"publisher","unstructured":"Shukla, R., Shukla, H., Sonkar, A., Pandey, T. & Tripathi, T. Structure-Based Screening And Molecular Dynamics Simulations Offer Novel Natural Compounds As Potential Inhibitors Of Mycobacterium Tuberculosis Isocitrate Lyase. J. Biomol. Struct. Dyn. 1\u2013106, doi:10.1080\/07391102.2017.1341337 (2017).","DOI":"10.1080\/07391102.2017.1341337"},{"key":"8842_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01235-z","volume":"7","author":"H Shukla","year":"2017","unstructured":"Shukla, H., Shukla, R., Sonkar, A., Pandey, T. & Tripathi, T. Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility. Sci. Rep. \n                           7, 1058, doi:10.1038\/s41598-017-01235-z (2017).","journal-title":"Sci. Rep."},{"key":"8842_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann, T. R. & Coffman, R. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. \n                           7, 145\u2013173 (1989).","journal-title":"Annu. Rev. Immunol."},{"key":"8842_CR29","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","volume":"17","author":"P Kaye","year":"2011","unstructured":"Kaye, P. & Aebischer, T. Visceral leishmaniasis: immunology and prospects for a vaccine. Clin. Microbiol. Infect. \n                           17, 1462\u20131470 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"8842_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/978-1-61779-501-5_25","volume":"835","author":"R de Jonge","year":"2012","unstructured":"de Jonge, R. In silico identification and characterization of effector catalogs. Methods Mol Biol. \n                           835, 415\u2013425 (2012).","journal-title":"Methods Mol Biol."},{"key":"8842_CR31","doi-asserted-by":"crossref","DOI":"10.1002\/j.1460-2075.1988.tb02787.x","volume":"7","author":"JB Rothbard","year":"1988","unstructured":"Rothbard, J. B. & Taylor, W. R. A sequence pattern common to T cell epitopes. The EMBO J. \n                           7, 93 (1988).","journal-title":"The EMBO J."},{"key":"8842_CR32","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/mr.60.3.512-538.1996","volume":"60","author":"SC Makrides","year":"1996","unstructured":"Makrides, S. C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. \n                           60, 512\u2013538 (1996).","journal-title":"Microbiol. Rev."},{"key":"8842_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jmr.893","volume":"21","author":"Y EL-Manzalawy","year":"2008","unstructured":"EL-Manzalawy, Y., Dobbs, D. & Honavar, V. Predicting linear B\u2010cell epitopes using string kernels. J. Mol. Recogn. \n                           21, 243\u2013255 (2008).","journal-title":"J. Mol. Recogn."},{"key":"8842_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J. et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. \n                           9, 514 (2008).","journal-title":"BMC Bioinformatics."},{"key":"8842_CR35","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. Protein identification and analysis tools on the ExPASy server (Springer, 2005).","DOI":"10.1385\/1-59259-890-0:571"},{"key":"8842_CR36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos, C. & Yeates, T. O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. \n                           2, 1511\u20131519 (1993).","journal-title":"Protein Sci."},{"key":"8842_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2174\/1386207319666160907100134","volume":"19","author":"RK Pandey","year":"2016","unstructured":"Pandey, R. K., Prajapati, P., Goyal, S., Grover, A. & Prajapati, V. K. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase. Comb. Chem. High. Throughput. Screen. \n                           19, 813\u2013823 (2016).","journal-title":"Comb. Chem. High. Throughput. Screen."},{"key":"8842_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/07391102.2015.1135298","volume":"35","author":"RK Pandey","year":"2017","unstructured":"Pandey, R. K. et al. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. J. Biomol. Struct. Dyn. \n                           35, 141\u2013158 (2017).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"8842_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/10799893.2016.1171344","volume":"37","author":"RK Pandey","year":"2017","unstructured":"Pandey, R. K., Kumbhar, B. V., Sundar, S., Kunwar, A. & Prajapati, V. K. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. J. Recept. Signal. Transduct. \n                           37, 60\u201370 (2017).","journal-title":"J. Recept. Signal. Transduct."},{"key":"8842_CR40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/07391102.2016.1161560","volume":"35","author":"RK Pandey","year":"2017","unstructured":"Pandey, R. K. et al. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation. J. Biomol. Struct. Dyn. \n                           35, 791\u2013804 (2017).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"8842_CR41","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1080\/07391102.2015.1085904","volume":"33","author":"RK Pandey","year":"2015","unstructured":"Pandey, R. K., Sharma, D., Bhatt, T. K., Sundar, S. & Prajapati, V. K. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. J. Biomol. Struct. Dyn. \n                           33, 2541\u20132553 (2015).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"8842_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biopha.2016.06.010","volume":"83","author":"RK Pandey","year":"2016","unstructured":"Pandey, R. K. et al. High-throughput virtual screening and quantum mechanics approach to develop imipramine analogues as leads against trypanothione reductase of leishmania. Biomed. Pharmacother. \n                           83, 141\u2013152 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"8842_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"HJ Berendsen","year":"1995","unstructured":"Berendsen, H. J., van der Spoel, D. & van Drunen, R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. \n                           91, 43\u201356 (1995).","journal-title":"Comput. Phys. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08842-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08842-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08842-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T03:46:29Z","timestamp":1671767189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08842-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8842"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08842-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]},"assertion":[{"value":"20 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8285"}}